ArticleCentral-European journal of immunology2025
LAMA1 derived from colorectal cancer promotes M2 polarization in macrophages
Article in Central-European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Shaping the macrophage landscape in the tumour microenvironment.Central-European journal of immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Although the development of certain malignancies is linked to aberrant expression of LAMA1, it is not yet known how precisely LAMA1 regulates macrophage M2 polarization and the malignant evolution of colorectal cancer (CRC). Material and methods: qRT-PCR and western blot (WB) were used to identify the expression of LAMA1 in human normal colonic epithelial cells (NCM-460) and CRC cell lines (RKO, LoVo). Using ELISA kits, the protein levels of LAMA1, interleukin (IL)-10, and Arg1 were determined. The assays used in the study included flow cytometry to evaluate CRC cell apoptosis and macrophage M2 polarization. Colony formation assessed the proliferative ability of co-cultured CRC cells, with Transwell assessing migration and invasion. WB identified the expression of proteins linked to the epithelial- mesenchymal transition (EMT). Results: In CRC cells, LAMA1 was overexpressed. LAMA1 generated from CRC stimulated the EGFR/AKT/CREB signaling pathway in macrophages to induce M2 polarization of macrophages and eventually promote CRC cell proliferation, migration, and invasion, as well as to activate the EMT process and block CRC cell apoptosis. Conclusions: As a pro-carcinogenic factor released by CRC cells, LAMA1 affects the activation of the EGFR/AKT/CREB pathway in macrophages, causing M2 polarization and aggravating the malignant evolution of CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.